Amarin Corp Plc (AMRN)

[HDGabor]

e-

you analysis is focusing too much on Kurabayashi and too less on fact Du has the USTPO ON HER SIDE!!!!

You are focusing too much on Mori, Hence, Mori is almost IRRELEVANT (the USPTO and Judge Du found that Mori support obviousness … and EPA vs DHA arm is irrelevant … it was not a null hypothesis ever), rather Kurabayashi is the key. (Mori will not be seen by the FC as "no teaching".) The USPTO did not see it as obvious and Judge Du interpreted incorrectly. The USPTO is not on HER SIDE regarding Kubayashi … but regarding Mori.

You're missing the point: Du can survive b/c "strong showing of obviousness."

You are missing the point: Du used Kurabayashi as "strong showing of obviousness." … meanwhile it is not … furthermore: it is an "unexpected benefit"

b/c we have 2 strong sec. cons. already.

Are two enough? Could be … but 3 is better than 2, especially if the third is "moving" from "strong showing of obviousness" to secondary consideration ("unexpected benefit").

Best,
G